Company / Shareholders' Equity
MESA LABORATORIES INC /CO/ Shareholders' Equity History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$186.2M
FY2026
5-year range
$145.4M / $406.2M
FY2022-FY2026
Trend
+16.5%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $98M in FY2017 to $406M in FY2023.
Based on SEC 10-K filings.
$186M in FY2026 with a 5-year CAGR of -14.4%.
Improved from $145M to $186M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -22.9%
- 5-Year CAGR
- -14.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.4%, indicating a declining trend.
- In FY2026, shareholders' equity increased 16.5% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
- Lowest shareholders' equity in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.03 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $186.2M | +16.5% |
| FY2025 | $159.8M | +9.9% |
| FY2024 | $145.4M | -64.2% |
| FY2023 | $406.2M | +3.2% |
| FY2022 | $393.8M | -3.1% |
| FY2021 | $406.2M | +84.6% |
| FY2020 | $220.0M | +97.7% |
| FY2019 | $111.3M | +12.0% |
| FY2018 | $99.4M | +1.6% |
| FY2017 | $97.8M | +15.5% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026